Skip to main content
. 2015 Dec 4;20(12):21750–21769. doi: 10.3390/molecules201219804

Table 1.

Recent applications of synthetic polymers in prodrug delivery.

Polymer Application (co)Polymer Prodrug Linker(bond) Ref.
PEG Gene delivery Polyethylenimine(PEI)-PEG cDNA of herpes simplex virus thymidine kinase gene (HSVtk) and granulocyte–macrophage colony-stimulating factor (GM-CSF) N.D. [21]
Tumor targeting octreotide(Phe)-PEG Paclitaxel [22]
Improved stability and intracellular drug release methoxy PEG-b-(poly(2-(diisopropylamino) ethyl methacrylate-co-aminopropyl methacrylamide) (PEDPA) Cis-aconityl-doxorubicin [23]
Tumor targeting PEG Fusion toxin consisting of the anti-EpCAM DARPin Ec1 and a domain I-deleted variant of ETA (ETA″) rhinovirus 3C model protease—cleavage linker [24]
Drug delivery 3,3′-dithiodipropionic acid functionalized PEG-b-poly(l-lysine) (mPEG-b-P(LL-DTPA)) Paclitaxel Disulfide [25]
Multidrug resistance D-α-tocopherol PEG succinate (TPGS) Paclitaxel Disulfide [26]
Improved the therapeutic efficacy β-CD, PEG Doxorubicin hydrazone [27]
Tumor targeting PEG Paclitaxel [28]
Multidrug resistance PEG-poly(d,l-lactide) 4-(N)-stearoyl Gemcitabine [29]
Theranosis PEG-polylactic acid (PEG-PLA) l Dicyanomethylene-4H-pyran-S-CPT Disulfide [30]
Tumor targeting PEG monomethyl ether (mPEG) Artesunate Ester [31]
Tumor targeting PEG monomethyl ether Camptothecin Disulfide [32]
Tumor targeting PEG Camptothecin Disulfide [33]
Tumor targeting PEG2000 Paclitaxel MMP2-cleavable linker [34]
Nanogel PLGA-PEG-PLGA PEGylated Taxol [35]
Drug delivery mPEG-b-P(ATMC-co-DTC) Doxorubicin Hydrazone [36]
HPMA improving anticancer therapy (mPEG5000-b-p(HPMAmLac2-r-AzEMA) Doxorubicin-glucuronide prodrug (DOX-propGA3) Glucuronide (β-glucuronidase cleavable linker) [37]
Prevent metastasis HPMA copolymer E-selectin binding peptide (Esbp)-doxorubicinor (KLAKLAK)2 [38]
Drug delivery HPMA copolymer H1-S6A, F8A peptide GFLG (Cathepsin cleavage linker) [39]
Tumor targeting HPMA copolymer Doxorubicin GFLG and MMP cleavable linker [40]
Improved the therapeutic efficacy HPMA copolymer Doxorubicin, 5-FU Hydrazone, GFLG [41]
Theranosis Star polymer: poly(amido amine) (PAMAM) dendrimers and HPMA Doxorubicin or TAMRA fluorescent dye Hydrazone [42]
Improved Bioavailability Star polymer: poly(amido amine) (PAMAM) dendrimers and HPMA Pirarubicin Hydrazone [43,44]
Drug delivery HPMA copolymer Iodine-125 Hydrazone [45]
Drug delivery HPMA copolymer Paclitaxel, Gemcitabine GFLG [46]
Drug delivery Starch + HPMA copolymer Camptothecin [47]
Gene delivery galactosylated 2-hydroxypropylmethacrylamide-s-3-guanidinopropyl methacrylamide (HPMAs–GPMA) shRNA [48]
Drug delivery HPMA Indium-111, Yttrium-90 [49]
Improved the therapeutic efficacy multiblock poly HPMA Gemcitabine, Paclitaxel and Doxorubicin GFLG [50]
Theranosis HPMA copolymer Zinc protoporphyrin [16,51]
SMA Photodynamic therapy SMA Zinc protoporphyrin Amide [52]
PLGA Improved Bioavailability PLGA Gemcitabine Amide [53]
PGG Improved Bioavailability PGG Paclitaxel Glutamic acid [54,55]